TRPs to cardiovascular disease

José C. González-Cobos, Xuexin Zhang, Rajender K. Motiani, Kelly E. Harmon, Mohamed Trebak

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Transient receptor potential (TRP) is a large superfamily of cation channels comprising 28 members in mammals. TRP channels are ubiquitously expressed in human tissues, including the cardiovascular system where they have been associated with a number of physiological functions, such as proliferation, contraction, and migration. TRP channels comprise six large families of cation channels: TRPC, TRPM, TRPV, TRPP, TRPA, and TRPML with diverse ion selectivities and modes of activation. Depending on the isoform considered, activation of TRP channels can cause entry of Ca2+, Na+, or Mg2+ into cells. TRP channels have recently emerged as attractive drug targets for treatment of cardiovascular diseases since their expression and/or activation was shown to be disturbed in certain pathophysiological conditions, such as cardiac hypertrophy and hypertension. In this short review, we will summarize data on the expression of TRP channels in the three major cell types of the cardiovascular system: cardiomyocytes, endothelial cells, and smooth muscle cells and will review evidence for the involvement of TRP channels in mediating cardiovascular disease.

Original languageEnglish (US)
Title of host publicationTRP Channels in Drug Discovery
Subtitle of host publicationVolume II
Editors Arpad Szallasi, Tamas Biro
Pages3-40
Number of pages38
DOIs
StatePublished - Nov 19 2012

Publication series

NameMethods in Pharmacology and Toxicology
ISSN (Print)1557-2153
ISSN (Electronic)1940-6053

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'TRPs to cardiovascular disease'. Together they form a unique fingerprint.

  • Cite this

    González-Cobos, J. C., Zhang, X., Motiani, R. K., Harmon, K. E., & Trebak, M. (2012). TRPs to cardiovascular disease. In A. Szallasi, & T. Biro (Eds.), TRP Channels in Drug Discovery: Volume II (pp. 3-40). (Methods in Pharmacology and Toxicology). https://doi.org/10.1007/978-1-62703-095-3_1